E2F1 and central nervous system cancer: We hypothesized that SNHG18 could facilitate the progression of glioma, and we demonstrated that SNHG18 could regulate the malignant biological behaviors of glioma cells and E2F1 bound to the SNHG18 promoter region to promote SNHG18 transcription.